ECM Weekly (14th March 2021) - Coupang, Baidu, Shanghai Heartcare, Chaoju Eye Care, Linklogis, Tuya
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.
363 Views
InnoCare Pharma Ltd (9969.HK) - What Attracts Both Hillhouse and Vivo Capital?
The article analyzed what InnoCare attracts both Hillhouse and Vivo Capital in terms of its core product orelabrutinib, other products (ICP-192/ICP...
314 Views
BeiGene: Cancer Treatment in China--The Underestimated Opportunity
We think that cancer is underdiagnosed and undertreated in China. We analyze the data and propose two approaches for investing in this theme.
330 Views
China Healthcare Weekly (Dec.31)
This article summarized the industry viewpoints including the results of China 2020 medical insurance negotiations, TDDS, companies news of...
322 Views
Hutchison China MediTech - To China and beyond
Hutchison China MediTech (HCM) continues to move swiftly towards its goal of globalization of its innovative oncology assets and building a fully...
103 Views